Trontinemab is a formulation of Roche's failed gantenerumab but now paired with the company's Brainshuttle technology to ...

The therapies, which are just starting to enter clinical trials, will need to prove clear clinical and quality-of-life ...

The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended regulators approve Servier's IDH1/2 inhibitor Voranigo (vorasidenib) as a treatment for ...

The Medicines and Healthcare Products Regulatory Agency said it will closely track adverse events associated with the treatment.